A new COVID-19 antiviral is on the horizon, but how does it fare?
A new oral antiviral might be more favourable than nirmatrelvir–ritonavir in shortening recovery times for at-risk adults with COVID-19, a study suggests. The China-based phase…
Tag: COVID-19 therapy
Remdesivir reduces COVID-19 hospitalisation or death by 84%
Findings challenge the drug’s controversial past
Molnupiravir still aids recovery from COVID-19: University of Oxford trial
Molnupiravir speeds up recovery in high-risk patients with COVID-19 but has no effect on death or hospitalisations compared with usual care, confirm the long-awaited results…
The year that was: Wuhan doctor reveals what really happened when COVID-19 struck
Here is the story of a doctor's life in a city under the control of a paranoid government obsessed with engineering perceptions.
Don’t rule out molnupiravir just yet, says RACGP
The RACGP is urging GPs to use their own clinical judgement when prescribing COVID-19 antivirals, following mixed messages regarding the appropriate use of molnupiravir. Last…
Is Professor Michael Kidd contradicting the national expert taskforce on prescribing molnupiravir?
This week a media storm burst after one of Australia’s top health officials issued a statement on the COVID-19 antiviral molnupiravir. The official turned out to be former RACGP…
Doctors told not to routinely prescribe molnupiravir for mild COVID-19
GPs are being advised against the routine use of molnupiravir to treat patients with mild COVID-19 following evidence the antiviral failed to reduce deaths or…
‘Last resort’ COVID-19 treatment outperforms molnupiravir in trial
A leading infectious diseases expert has urged health authorities to rethink their stance on the COVID-19 treatment sotrovimab, with new evidence suggesting it may outperform…
‘Exciting’: Antiviral shows promise in reducing long COVID symptoms
A leading infectious diseases expert is cautiously optimistic that nirmatrelvir/ritonavir can reduce the risk of long-term health outcomes in patients with COVID-19. A pre-print study…
COVID-19 antivirals likely to be added to the doctor’s bag
GPs may soon be able to dispense COVID-19 antivirals directly to their patients after the PBAC signed off on an RACGP proposal for a new…
